Myeloid C-type lectin receptors in viral recognition and antiviral immunity

Viruses

Volumn 9, Issue 3, 2017, Pages

  Monteiro, João T ^a   Lepenies, Bernd ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Antiviral immunity; C type lectin receptors; Dendritic cells; Glycans; Immunomodulation; Macrophages; Viral evasion

Indexed keywords

ANTIVIRUS AGENT; C TYPE LECTIN RECEPTOR; CD209 ANTIGEN; DENDRITIC CELL IMMUNORECEPTOR; FULLERENE DERIVATIVE; GLYCAN; GLYCOCONJUGATE; GLYCOPROTEIN; LANGERIN; LECTIN RECEPTOR; LIVER AND LYMPH NODE SINUSOIDAL ENDOTHELIAL CELL C TYPE LECTIN; LYMPH NODE SPECIFIC INTERCELLULAR ADHESION MOLECULE 3 GRABBING INTEGRIN; MACROPHAGE GALACTOSE TYPE LECTIN; MACROPHAGE MANNOSE RECEPTOR; MYELOID DAP 12 ASSOCIATING LECTIN; UNCLASSIFIED DRUG; LECTIN;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; BONE MARROW CELL; DENDRITIC CELL; EBOLA HEMORRHAGIC FEVER; GLYCOSYLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE EVASION; IMMUNITY; IMMUNOMODULATION; INNATE IMMUNITY; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; T LYMPHOCYTE ACTIVATION; VIRAL CLEARANCE; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS INFECTION; ANIMAL; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; PATHOGENICITY; VIRUS;

ADAPTIVE IMMUNITY; ANIMALS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; LECTINS, C-TYPE; VIRUS DISEASES; VIRUSES;

EID: 85016112890     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v9030059     Document Type: Review

References (161)

1. Murphy, K.; Travers, P.; Walport, M.; Janeway, C. Janeway’s Immunobiology; Garland Science: New York, NY, USA, 2012.
2. Beutler, B. Innate immunity: An overview. Mol. Immunol. 2004, 40, 845-859. [CrossRef] [PubMed]
3. Bonilla, F.A.; Oettgen, H.C. Adaptive immunity. J. Allergy Clin. Immunol. 2010, 125, S33-S40. [CrossRef] [PubMed]
4. Akira, S.; Uematsu, S.; Takeuchi, O. Pathogen Recognition and Innate Immunity. Cell 2006, 124, 783-801. [CrossRef] [PubMed]
5. Chaplin, D.D. Overview of the immune response. J. Allergy Clin. Immunol. 2010, 125, S3-S23. [CrossRef] [PubMed]
6. Takeuchi, O.; Akira, S. Pattern Recognition Receptors and Inflammation. Cell 2010, 140, 805-820. [CrossRef] [PubMed]
7. Kanneganti, T.D.; Lamkanfi, M.; Nunez, G. Intracellular NOD-like receptors in host defense and disease. Immunity 2007, 27, 549-559. [CrossRef] [PubMed]
8. Loo, Y.-M.; Gale, M., Jr. Immune Signaling by RIG-I-like Receptors. Immunity 2016, 34, 680-692. [CrossRef] [PubMed]
9. Takaoka, A.; Wang, Z.; Choi, M.K.; Yanai, H.; Negishi, H.; Ban, T.; Lu, Y.; Miyagishi, M.; Kodama, T.; Honda, K.; Ohba, Y.; Taniguchi, T. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007, 448, 501-505. [CrossRef] [PubMed]
10. Dambuza, I.M.; Brown, G.D. C-type lectins in immunity: Recent developments. Curr. Opin. Immunol. 2015, 32, 21-27. [CrossRef] [PubMed]
11. Robinson, M.J.; Sancho, D.; Slack, E.C.; LeibundGut-Landmann, S.; Sousa, C.R. e Myeloid C-type lectins in innate immunity. Nat. Immunol. 2006, 7, 1258-1265. [CrossRef] [PubMed]
12. Dam, T.K.; Fred Brewer, C. Lectins as pattern recognition molecules: The effects of epitope density in innate immunity. Glycobiology 2009, 20, 270-279. [CrossRef] [PubMed]
13. Sancho, D.; Reise Sousa, C. Signaling by Myeloid C-Type Lectin Receptors in Immunity and Homeostasis. Annu. Rev. Immunol. 2012, 30, 491-529. [CrossRef] [PubMed]
14. van Vliet, S.J.; Garcia-Vallejo, J.J.; van Kooyk, Y. Dendritic cells and C-type lectin receptors: Coupling innate to adaptive immune responses. Immunol. Cell Biol. 2008, 86, 580-587. [CrossRef] [PubMed]
15. Tortorella, D.; Gewurz, B.E.; Furman, M.H.; Schust, D.J.; Ploegh, H.L. Viral Subversion of the Immune System. Annu. Rev. Immunol. 2000, 18, 861-926. [CrossRef] [PubMed]
16. Varki, A.; Cummings, R.D.; Esko, J.D.; Hart, G.; Stanley, P.; Aebi, M.; Darvill, A.; Kinoshita, T.; Packer, N.H. Essentials of Glycobiology, 3rd ed.; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, USA, 2017.
17. Taylor, M.E.; Drickamer, K. Introduction to Glycobiology; OUP Oxford: Toronto, ON, Canada, 2011.
18. Schwarz, F.; Aebi, M. Mechanisms and principles of N-linked protein glycosylation. Curr. Opin. Struct. Biol. 2011, 21, 576-582. [CrossRef] [PubMed]
19. Lyons, J.J.; Milner, J.D.; Rosenzweig, S.D. Glycans Instructing Immunity: The Emerging Role of Altered Glycosylation in Clinical Immunology. Front. Pediatr. 2015, 3, 54. [CrossRef] [PubMed]
20. Wopereis, S.; Lefeber, D.J.; Morava, É.; Wevers, R.A. Mechanisms in Protein O-Glycan Biosynthesis and Clinical and Molecular Aspects of Protein O-Glycan Biosynthesis Defects: A Review. Clin. Chem. 2006, 52, 574LP-600LP. [CrossRef] [PubMed]
21. Varki, A. Sialic acids in human health and disease. Trends Mol. Med. 2008, 14, 351-360. [CrossRef] [PubMed]
22. Angata, T.; Varki, A. Chemical Diversity in the Sialic Acids and Related α-Keto Acids: An Evolutionary Perspective. Chem. Rev. 2002, 102, 439-470. [CrossRef] [PubMed]
23. Stencel-Baerenwald, J.E.; Reiss, K.; Reiter, D.M.; Stehle, T.; Dermody, T.S. The sweet spot: Defining virus-sialic acid interactions. Nat. Rev. Micro 2014, 12, 739-749. [CrossRef] [PubMed]
24. Van Breedam, W.; Pöhlmann, S.; Favoreel, H.W.; de Groot, R.J.; Nauwynck, H.J. Bitter-sweet symphony: Glycan-lectin interactions in virus biology. FEMS Microbiol. Rev. 2014, 38, 598-632. [CrossRef] [PubMed]
25. Viswanathan, K.; Chandrasekaran, A.; Srinivasan, A.; Raman, R.; Sasisekharan, V.; Sasisekharan, R. Glycans as receptors for influenza pathogenesis. Glycoconj. J. 2010, 27, 561-570. [CrossRef] [PubMed]
26. Vigerust, D.J.; Shepherd, V.L. Virus glycosylation: Role in virulence and immune interactions. Trends Microbiol. 2007, 15, 211-218. [CrossRef] [PubMed]
27. Goffard, A.; Callens, N.; Bartosch, B.; Wychowski, C.; Cosset, F.-L.; Montpellier, C.; Dubuisson, J. Role of N-Linked Glycans in the Functions of Hepatitis C Virus Envelope Glycoproteins. J. Virol. 2005, 79, 8400-8409. [CrossRef] [PubMed]
28. Beyene, A.; Basu, A.; Meyer, K.; Ray, R. Influence of N-linked glycans on intracellular transport of hepatitis C virus E1 chimeric glycoprotein and its role in pseudotype virus infectivity. Virology 2004, 324, 273-285. [CrossRef] [PubMed]
29. Doores, K.J. The HIV glycan shield as a target for broadly neutralizing antibodies. FEBS J. 2015, 282, 4679-4691. [CrossRef] [PubMed]
30. Drickamer, K.; Taylor, M.E. Recent insights into structures and functions of C-type lectins in the immune system. Curr. Opin. Struct. Biol. 2015, 34, 26-34. [CrossRef] [PubMed]
31. Zelensky, A.N.; Gready, J.E. The C-type lectin-like domain superfamily. FEBS J. 2005, 272, 6179-6217. [CrossRef] [PubMed]
32. Kiyotake, R.; Oh-hora, M.; Ishikawa, E.; Miyamoto, T.; Ishibashi, T.; Yamasaki, S. Human Mincle Binds to Cholesterol Crystals and Triggers Innate Immune Responses. J. Biol. Chem. 2015, 290, 25322-25332. [CrossRef] [PubMed]
33. Neumann, K.; Castiñeiras-Vilariño, M.; Höckendorf, U.; Hannesschläger, N.; Lemeer, S.; Kupka, D.; Meyermann, S.; Lech, M.; Anders, H.-J.; Kuster, B.; et al. Clec12a Is an Inhibitory Receptor for Uric Acid Crystals that Regulates Inflammation in Response to Cell Death. Immunity 2016, 40, 389-399. [CrossRef] [PubMed]
34. Steinman, R.M.; Hemmi, H. Dendritic Cells: Translating Innate to Adaptive Immunity. In From Innate Immunity to Immunological Memory; Pulendran, B., Ahmed, R., Eds.; Springer: Berlin/Heidelberg, Germany, 2006; pp. 17-58.
35. Mayer, S.; Raulf, M.-K.; Lepenies, B. C-type lectins: Their network and roles in pathogen recognition and immunity. Histochem. Cell Biol. 2017, 147, 223-237. [CrossRef] [PubMed]
36. Osorio, F.; Reise Sousa, C. Myeloid C-type Lectin Receptors in Pathogen Recognition and Host Defense. Immunity 2011, 34, 651-664. [CrossRef] [PubMed]
37. Geijtenbeek, T.B.H.; Gringhuis, S.I. Signalling through C-type lectin receptors: Shaping immune responses. Nat. Rev. Immunol. 2009, 9, 465-479. [CrossRef] [PubMed]
38. Kerrigan, A.M.; Brown, G.D. Syk-coupled C-type lectins in immunity. Trends Immunol. 2011, 32, 151-156. [CrossRef] [PubMed]
39. Deng, Z.; Ma, S.; Zhou, H.; Zang, A.; Fang, Y.; Li, T.; Shi, H.; Liu, M.; Du, M.; Taylor, P.R.; et al. Tyrosine phosphatase SHP-2 mediates C-type lectin receptor-induced activation of the kinase Syk and anti-fungal TH17 responses. Nat. Immunol. 2015, 16, 642-652. [CrossRef] [PubMed]
40. Mason, C.P.; Tarr, A.W. Human lectins and their roles in viral infections. Molecules 2015, 20, 2229-2271. [CrossRef] [PubMed]
41. Liu, Y.; Liu, J.; Pang, X.; Liu, T.; Ning, Z.; Cheng, G. The roles of direct recognition by animal lectins in antiviral immunity and viral pathogenesis. Molecules 2015, 20, 2272-2295. [CrossRef] [PubMed]
42. Geijtenbeek, T.B.H.; Torensma, R.; van Vliet, S.J.; van Duijnhoven, G.C.F.; Adema, G.J.; van Kooyk, Y.; Figdor, C.G. Identification of DC-SIGN, a Novel Dendritic Cell-Specific ICAM-3 Receptor that Supports Primary Immune Responses. Cell 2000, 100, 575-585. [CrossRef]
43. Mitchell, D.A.; Fadden, A.J.; Drickamer, K. A Novel Mechanism of Carbohydrate Recognition by the C-type Lectins DC-SIGN and DC-SIGNR: Subunit Organization and Binding to Multivalent Ligands. J. Biol. Chem. 2001, 276, 28939-28945. [CrossRef] [PubMed]
44. Khoo, U.-S.; Chan, K.Y.K.; Chan, V.S.F.; Lin, C.L.S. DC-SIGN and L-SIGN: The SIGNs for infection. J. Mol. Med. 2008, 86, 861-874. [CrossRef] [PubMed]
45. Ganguly, D.; Haak, S.; Sisirak, V.; Reizis, B. The role of dendritic cells in autoimmunity. Nat. Rev. Immunol. 2013, 13, 566-577. [CrossRef] [PubMed]
46. van Liempt, E.; Bank, C.M.C.; Mehta, P.; García-Vallejo, J.J.; Kawar, Z.S.; Geyer, R.; Alvarez, R.A.; Cummings, R.D.; Kooyk, Y.; van Die, I. Specificity of DC-SIGN for mannose- and fucose-containing glycans. FEBS Lett. 2006, 580, 6123-6131. [CrossRef] [PubMed]
47. Iborra, S.; Sancho, D. Signalling versatility following self and non-self sensing by myeloid C-type lectin receptors. Immunobiology 2015, 220, 175-184. [CrossRef] [PubMed]
48. Tassaneetrithep, B.; Burgess, T.H.; Granelli-Piperno, A.; Trumpfheller, C.; Finke, J.; Sun, W.; Eller, M.A.; Pattanapanyasat, K.; Sarasombath, S.; Birx, D.L.; et al. DC-SIGN (CD209) Mediates Dengue Virus Infection of Human Dendritic Cells. J. Exp. Med. 2003, 197, 823-829. [CrossRef] [PubMed]
49. Marzi, A.; Gramberg, T.; Simmons, G.; Möller, P.; Rennekamp, A.J.; Krumbiegel, M.; Geier, M.; Eisemann, J.; Turza, N.; Saunier, B.; et al. DC-SIGN and DC-SIGNR Interact with the Glycoprotein of Marburg Virus and the S Protein of Severe Acute Respiratory Syndrome Coronavirus. J. Virol. 2004, 78, 12090-12095. [CrossRef] [PubMed]
50. Baribaud, F.; Pöhlmann, S.; Leslie, G.; Mortari, F.; Doms, R.W. Quantitative Expression and Virus Transmission Analysis of DC-SIGN on Monocyte-Derived Dendritic Cells. J. Virol. 2002, 76, 9135-9142. [CrossRef] [PubMed]
51. Lin, G.; Simmons, G.; Pöhlmann, S.; Baribaud, F.; Ni, H.; Leslie, G.J.; Haggarty, B.S.; Bates, P.; Weissman, D.; Hoxie, J.A.; et al. Differential N-Linked Glycosylation of Human Immunodeficiency Virus and Ebola Virus Envelope Glycoproteins Modulates Interactions with DC-SIGN and DC-SIGNR. J. Virol. 2003, 77, 1337-1346. [CrossRef] [PubMed]
52. Marzi, A.; Möller, P.; Hanna, S.L.; Harrer, T.; Eisemann, J.; Steinkasserer, A.; Becker, S.; Baribaud, F.; Pöhlmann, S. Analysis of the Interaction of Ebola Virus Glycoprotein with DC-SIGN (Dendritic Cell-Specific Intercellular Adhesion Molecule 3-Grabbing Nonintegrin) and Its Homologue DC-SIGNR. J. Infect. Dis. 2007, 196, S237-S246. [CrossRef] [PubMed]
53. van Kooyk, Y.; Geijtenbeek, T.B.H. DC-SIGN: Escape mechanism for pathogens. Nat. Rev. Immunol. 2003, 3, 697-709. [CrossRef] [PubMed]
54. Geijtenbeek, T.B.H.; Kwon, D.S.; Torensma, R.; van Vliet, S.J.; van Duijnhoven, G.C.F.; Middel, J.; Cornelissen, I.L.M.H.; Nottet, H.S.L.M.; KewalRamani, V.N.; Littman, D.R.; et al. DC-SIGN, a Dendritic Cell-Specific HIV-1-Binding Protein that Enhances trans-Infection of T cells. Cell 2000, 100, 587-597. [CrossRef]
55. Haase, A.T. Targeting early infection to prevent HIV-1 mucosal transmission. Nature 2010, 464, 217-223. [CrossRef] [PubMed]
56. Gringhuis, S.I.; van der Vlist, M.; van den Berg, L.M.; den Dunnen, J.; Litjens, M.; Geijtenbeek, T.B.H. HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells. Nat. Immunol. 2010, 11, 419-426. [PubMed]
57. Miyauchi, K.; Kim, Y.; Latinovic, O.; Morozov, V.; Melikyan, G.B. HIV Enters Cells via Endocytosis and Dynamin-Dependent Fusion with Endosomes. Cell 2009, 137, 433-444. [CrossRef] [PubMed]
58. van Montfort, T.; Eggink, D.; Boot, M.; Tuen, M.; Hioe, C.E.; Berkhout, B.; Sanders, R.W. HIV-1 N-Glycan Composition Governs a Balance between Dendritic Cell-Mediated Viral Transmission and Antigen Presentation. J. Immunol. 2011, 187, 4676-4685. [CrossRef] [PubMed]
59. McDonald, D. Dendritic Cells and HIV-1 Trans-Infection. Viruses 2010, 2, 1704-1717. [CrossRef] [PubMed]
60. McDonald, D.; Wu, L.; Bohks, S.M.; KewalRamani, V.N.; Unutmaz, D.; Hope, T.J. Recruitment of HIV and Its Receptors to Dendritic Cell-T Cell Junctions. Science 2003, 300, 1295-1297. [CrossRef] [PubMed]
61. Hodges, A. Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication. Nat. Immunol. 2007, 8, 569-577. [CrossRef] [PubMed]
62. Chen, Y.; Hwang, S.-L.; Chan, V.S.F.; Chung, N.P.Y.; Wang, S.-R.; Li, Z.; Ma, J.; Lin, C.-W.; Hsieh, Y.-J.; Chang, K.-P.; et al. Binding of HIV-1 gp120 to DC-SIGN Promotes ASK-1-Dependent Activation-Induced Apoptosis of Human Dendritic Cells. PLoS Pathog. 2013, 9, e1003100. [CrossRef] [PubMed]
63. Lozach, P.-Y.; Burleigh, L.; Staropoli, I.; Amara, A. The C Type Lectins DC-SIGN and L-SIGN. In Glycovirology Protocols SE - 4; Sugrue, R., Ed.; Methods in Molecular Biology; Humana Press: Totowa, NJ, USA, 2007; Volume 379, pp. 51-68.
64. Celerino da Silva, R.; Segat, L.; Crovella, S. Role of DC-SIGN and L-SIGN receptors in HIV-1 vertical transmission. Hum. Immunol. 2011, 72, 305-311. [CrossRef] [PubMed]
65. Ludwig, I.S.; Lekkerkerker, A.N.; Depla, E.; Bosman, F.; Musters, R.J.P.; Depraetere, S.; van Kooyk, Y.; Geijtenbeek, T.B.H. Hepatitis C Virus Targets DC-SIGN and L-SIGN To Escape Lysosomal Degradation. J. Virol. 2004, 78, 8322-8332. [CrossRef] [PubMed]
66. Simmons, G.; Reeves, J.D.; Grogan, C.C.; Vandenberghe, L.H.; Baribaud, F.; Whitbeck, J.C.; Burke, E.; Buchmeier, M.J.; Soilleux, E.J.; Riley, J.L.; et al. DC-SIGN and DC-SIGNR Bind Ebola Glycoproteins and Enhance Infection of Macrophages and Endothelial Cells. Virology 2003, 305, 115-123. [CrossRef] [PubMed]
67. Klimstra, W.B.; Nangle, E.M.; Smith, M.S.; Yurochko, A.D.; Ryman, K.D. DC-SIGN and L-SIGN Can Act as Attachment Receptors for Alphaviruses and Distinguish between Mosquito Cell- and Mammalian Cell-Derived Viruses. J. Virol. 2003, 77, 12022-12032. [CrossRef] [PubMed]
68. Op den Brouw, M.L.; De Jong, M.A.W.P.; Ludwig, I.S.; Van Der Molen, R.G.; Janssen, H.L.A.; Geijtenbeek, T.B.H.; Woltman, A.M. Branched oligosaccharide structures on HBV prevent interaction with both DC-SIGN and L-SIGN. J. Viral Hepat. 2008, 15, 675-683. [CrossRef] [PubMed]
69. Han, D.P.; Lohani, M.; Cho, M.W. Specific Asparagine-Linked Glycosylation Sites Are Critical for DC-SIGNand L-SIGN-Mediated Severe Acute Respiratory Syndrome Coronavirus Entry. J. Virol. 2007, 81, 12029-12039. [CrossRef] [PubMed]
70. Brauburger, K.; Hume, A.J.; Mühlberger, E.; Olejnik, J. Forty-Five Years of Marburg Virus Research. Viruses 2012, 4, 1878-1927. [CrossRef] [PubMed]
71. Davis, C.W.; Nguyen, H.-Y.; Hanna, S.L.; Sánchez, M.D.; Doms, R.W.; Pierson, T.C. West Nile Virus Discriminates between DC-SIGN and DC-SIGNR for Cellular Attachment and Infection. J. Virol. 2006, 80, 1290-1301. [CrossRef] [PubMed]
72. Léger, P.; Tetard, M.; Youness, B.; Cordes, N.; Rouxel, R.N.; Flamand, M.; Lozach, P.-Y. Differential Use of the C-Type Lectins L-SIGN and DC-SIGN for Phlebovirus Endocytosis. Traffic 2016, 17, 639-656. [CrossRef] [PubMed]
73. Gillespie, L.; Roosendahl, P.; Ng, W.C.; Brooks, A.G.; Reading, P.C.; Londrigan, S.L. Endocytic function is critical for influenza A virus infection via DC-SIGN and L-SIGN. Sci. Rep. 2016, 6, 19428. [CrossRef] [PubMed]
74. Zhang, F.; Ren, S.; Zuo, Y. DC-SIGN, DC-SIGNR and LSECtin: C-Type Lectins for Infection. Int. Rev. Immunol. 2014, 33, 54-66. [CrossRef] [PubMed]
75. Liu, W.; Tang, L.; Zhang, G.; Wei, H.; Cui, Y.; Guo, L.; Gou, Z.; Chen, X.; Jiang, D.; Zhu, Y.; et al. Characterization of a Novel C-type Lectin-like Gene, LSECtin: Demonstration of carbohydrate binding and expression in sinusoidal endothelial cells of liver and lymph node. J. Biol. Chem. 2004, 279, 18748-18758. [CrossRef] [PubMed]
76. Gramberg, T.; Hofmann, H.; Möller, P.; Lalor, P.F.; Marzi, A.; Geier, M.; Krumbiegel, M.; Winkler, T.; Kirchhoff, F.; Adams, D.H.; et al. LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus. Virology 2005, 340, 224-236. [CrossRef] [PubMed]
77. Gramberg, T.; Soilleux, E.; Fisch, T.; Lalor, P.F.; Hofmann, H.; Wheeldon, S.; Cotterill, A.; Wegele, A.; Winkler, T.; Adams, D.H.; Pöhlmann, S. Interactions of LSECtin and DC-SIGN/DC-SIGNR with viral ligands: Differential pH dependence, internalization and virion binding. Virology 2008, 373, 189-201. [CrossRef] [PubMed]
78. Dominguez-Soto, A.; Aragoneses-Fenoll, L.; Martin-Gayo, E.; Martinez-Prats, L.; Colmenares, M.; Naranjo-Gomez, M.; Borras, F.E.; Munoz, P.; Zubiaur, M.; Toribio, M.L.; et al. The DC-SIGN-related lectin LSECtin mediates antigen capture and pathogen binding by human myeloid cells. Blood 2007, 109, 5337-5345. [CrossRef] [PubMed]
79. Tang, L.; Yang, J.; Liu, W.; Tang, X.; Chen, J.; Zhao, D.; Wang, M.; Xu, F.; Lu, Y.; Liu, B.; et al. Liver Sinusoidal Endothelial Cell Lectin, LSECtin, Negatively Regulates Hepatic T-Cell Immune Response. Gastroenterology 2009, 137, 1498-1508.e5. [CrossRef] [PubMed]
80. Liang, Y.; Kwota, Z.; Sun, J. Intrahepatic regulation of antiviral T cell responses at initial stages of viral infection. Int. Immunopharmacol. 2016, 39, 106-112. [CrossRef] [PubMed]
81. Liu, B.; Wang, M.; Wang, X.; Zhao, D.; Liu, D.; Liu, J.; Chen, P.-J.; Yang, D.; He, F.; Tang, L. Liver Sinusoidal Endothelial Cell Lectin Inhibits CTL-Dependent Virus Clearance in Mouse Models of Viral Hepatitis. J. Immunol. 2013, 190, 4185-4195. [CrossRef] [PubMed]
82. Stoitzner, P.; Romani, N. Langerin, the “Catcher in the Rye”: An important receptor for pathogens on Langerhans cells. Eur. J. Immunol. 2011, 41, 2526-2529. [CrossRef] [PubMed]
83. Valladeau, J.; Ravel, O.; Dezutter-Dambuyant, C.; Moore, K.; Kleijmeer, M.; Liu, Y.; Duvert-Frances, V.; Vincent, C.; Schmitt, D.; Davoust, J.; et al. Langerin, a Novel C-Type Lectin Specific to Langerhans Cells, Is an Endocytic Receptor that Induces the Formation of Birbeck Granules. Immunity 2000, 12, 71-81. [CrossRef]
84. Stambach, N.S.; Taylor, M.E. Characterization of carbohydrate recognition by langerin, a C-type lectin of Langerhans cells. Glycobiol. 2003, 13, 401-410. [CrossRef] [PubMed]
85. van der Vlist, M.; Geijtenbeek, T.B.H. Langerin functions as an antiviral receptor on Langerhans cells. Immunol. Cell Biol. 2010, 88, 410-415. [CrossRef] [PubMed]
86. de Jong, M.A.W.P.; Vriend, L.E.M.; Theelen, B.; Taylor, M.E.; Fluitsma, D.; Boekhout, T.; Geijtenbeek, T.B.H. C-type lectin Langerin is a β-glucan receptor on human Langerhans cells that recognizes opportunistic and pathogenic fungi. Mol. Immunol. 2010, 47, 1216-1225. [CrossRef] [PubMed]
87. Cunningham, A.L.; Abendroth, A.; Jones, C.; Nasr, N.; Turville, S. Viruses and Langerhans cells. Immunol. Cell Biol. 2010, 88, 416-423. [CrossRef] [PubMed]
88. deWitte, L.; Nabatov, A.; Pion, M.; Fluitsma, D.; de Jong, M.A.W.P.; de Gruijl, T.; Piguet, V.; van Kooyk, Y.; Geijtenbeek, T.B.H. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat. Med. 2007, 13, 367-371. [CrossRef] [PubMed]
89. de Jong, M.A.W.P.; de Witte, L.; Oudhoff, M.J.; Gringhuis, S.I.; Gallay, P.; Geijtenbeek, T.B.H. TNF-α and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo. J. Clin. Investig. 2008, 118, 3440-3452. [CrossRef] [PubMed]
90. van der Vlist, M.; de Witte, L.; de Vries, R.D.; Litjens, M.; de Jong, M.A.W.P.; Fluitsma, D.; de Swart, R.L.; Geijtenbeek, T.B.H. Human Langerhans cells capture measles virus through Langerin and present viral antigens to CD4+ T cells but are incapable of cross-presentation. Eur. J. Immunol. 2011, 41, 2619-2631. [CrossRef] [PubMed]
91. Ng, W.C.; Londrigan, S.L.; Nasr, N.; Cunningham, A.L.; Turville, S.; Brooks, A.G.; Reading, P.C. The C-type lectin langerin functions as a receptor for attachment and infectious entry of influenza A virus. J. Virol. 2015. [CrossRef] [PubMed]
92. Bloem, K.; Vuist, I.M.; van den Berk, M.; Klaver, E.J.; van Die, I.; Knippels, L.M.J.; Garssen, J.; García-Vallejo, J.J.; van Vliet, S.J.; van Kooyk, Y. DCIR interacts with ligands from both endogenous and pathogenic origin. Immunol. Lett. 2014, 158, 33-41. [CrossRef] [PubMed]
93. Lambert, A.A.; Imbeault, M.; Gilbert, C.; Tremblay, M.J. HIV-1 Induces DCIR Expression in CD4+ T cells. PLoS Pathog. 2010, 6, e1001188. [CrossRef] [PubMed]
94. Bloem, K.; Vuist, I.M.; van der Plas, A.-J.; Knippels, L.M.J.; Garssen, J.; García-Vallejo, J.J.; van Vliet, S.J.; van Kooyk, Y. Ligand Binding and Signaling of Dendritic Cell Immunoreceptor (DCIR) Is Modulated by the Glycosylation of the Carbohydrate Recognition Domain. PLoS ONE 2013, 8, e66266. [CrossRef] [PubMed]
95. Fujikado, N.; Saijo, S.; Yonezawa, T.; Shimamori, K.; Ishii, A.; Sugai, S.; Kotaki, H.; Sudo, K.; Nose, M.; Iwakura, Y. Dcir deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells. Nat. Med. 2008, 14, 176-180. [CrossRef] [PubMed]
96. Meyer-Wentrup, F.; Benitez-Ribas, D.; Tacken, P.J.; Punt, C.J.A.; Figdor, C.G.; de Vries, I.J.M.; Adema, G.J. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-α production. Blood 2008, 111, 4245-4253. [CrossRef] [PubMed]
97. Klechevsky, E.; Flamar, A.-L.; Cao, Y.; Blanck, J.-P.; Liu, M.; O’Bar, A.; Agouna-Deciat, O.; Klucar, P.; Thompson-Snipes, L.; Zurawski, S.; et al. Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR. Blood 2010, 116, 1685-1697. [CrossRef] [PubMed]
98. Lambert, A.A.; Gilbert, C.; Richard, M.; Beaulieu, A.D.; Tremblay, M.J. The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways. Blood 2008, 112, 1299-1307. [CrossRef] [PubMed]
99. Lambert, A.A.; Barabé, F.; Gilbert, C.; Tremblay, M.J. DCIR-mediated enhancement of HIV-1 infection requires the ITIM-associated signal transduction pathway. Blood 2011, 117, 6589-6599. [CrossRef] [PubMed]
100. Flamar, A.-L.; Contreras, V.; Zurawski, S.; Montes, M.; Dereuddre-Bosquet, N.; Martinon, F.; Banchereau, J.; Le Grand, R.; Zurawski, G.; Levy, Y. Delivering HIV Gagp24 to DCIR Induces Strong Antibody Responses In Vivo. PLoS ONE 2015, 10, e0135513. [CrossRef] [PubMed]
101. Long, K.M.; Whitmore, A.C.; Ferris, M.T.; Sempowski, G.D.; McGee, C.; Trollinger, B.; Gunn, B.; Heise, M.T. Dendritic Cell Immunoreceptor Regulates Chikungunya Virus Pathogenesis in Mice. J. Virol. 2013, 87, 5697-5706. [CrossRef] [PubMed]
102. Maglinao, M.; Klopfleisch, R.; Seeberger, P.H.; Lepenies, B. The C-Type Lectin Receptor DCIR Is Crucial for the Development of Experimental Cerebral Malaria. J. Immunol. 2013, 191, 2551-2559. [CrossRef] [PubMed]
103. Bakker, A.B.H.; Baker, E.; Sutherland, G.R.; Phillips, J.H.; Lanier, L.L. Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells. Proc. Natl. Acad. Sci. USA 1999, 96, 9792-9796. [CrossRef] [PubMed]
104. Yim, D.; Jie, H.-B.; Sotiriadis, J.; Kim, Y.-S.; Kim, Y.B. Molecular Cloning and Expression Pattern of Porcine Myeloid DAP12-Associating Lectin-1. Cell. Immunol. 2001, 209, 42-48. [CrossRef] [PubMed]
105. Lanier, L.L.; Bakker, A.B.H. The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function. Immunol. Today 2000, 21, 611-614. [CrossRef]
106. Watson, A.A.; Lebedev, A.A.; Hall, B.A.; Fenton-May, A.E.; Vagin, A.A.; Dejnirattisai, W.; Felce, J.; Mongkolsapaya, J.; Palma, A.S.; Liu, Y.; et al. Structural Flexibility of the Macrophage Dengue Virus Receptor CLEC5A: Implications for Ligand Binding and Signaling. J. Biol. Chem. 2011, 286, 24208-24218. [CrossRef] [PubMed]
107. Watson, A.A.; O’Callaghan, C.A. Crystallization and X-ray diffraction analysis of human CLEC5A (MDL-1), a dengue virus receptor. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 2010, 66, 29-31. [CrossRef] [PubMed]
108. Chen, S.-T.; Lin, Y.-L.; Huang, M.-T.; Wu, M.-F.; Cheng, S.-C.; Lei, H.-Y.; Lee, C.-K.; Chiou, T.-W.; Wong, C.-H.; Hsieh, S.-L. CLEC5A is critical for dengue-virus-induced lethal disease. Nature 2008, 453, 672-676. [CrossRef] [PubMed]
109. Chen, S.-T.; Liu, R.-S.; Wu, M.-F.; Lin, Y.-L.; Chen, S.-Y.; Tan, D.T.-W.; Chou, T.-Y.; Tsai, I.-S.; Li, L.; Hsieh, S.-L. CLEC5A Regulates Japanese Encephalitis Virus-Induced Neuroinflammation and Lethality. PLoS Pathog. 2012, 8, e1002655. [CrossRef] [PubMed]
110. Teng, O.; Chen, S.-T.; Hsu, T.-L.; Sia, S.F.; Cole, S.; Valkenburg, S.A.; Hsu, T.-Y.; Zheng, J.T.; Tu, W.; Bruzzone, R.; et al. CLEC5A-mediated enhancement of the inflammatory response in myeloid cells contributes to influenza pathogenicity in vivo. J. Virol. 2016.
111. Khetarpal, N.; Khanna, I. Dengue Fever: Causes, Complications, and Vaccine Strategies. J. Immunol. Res. 2016, 2016, 6803098. [CrossRef] [PubMed]
112. Wu, M.-F.; Chen, S.-T.; Yang, A.-H.; Lin, W.-W.; Lin, Y.-L.; Chen, N.-J.; Tsai, I.-S.; Li, L.; Hsieh, S.-L. CLEC5A is critical for dengue virus-induced inflammasome activation in human macrophages. Blood 2013, 121, 95-106. [CrossRef] [PubMed]
113. Pang, T.; Cardosa, M.J.; Guzman, M.G. Of cascades and perfect storms: The immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF//DSS). Immunol. Cell Biol. 2006, 85, 43-45. [CrossRef] [PubMed]
114. Wu, M.-F.; Chen, S.-T.; Hsieh, S.-L. Distinct regulation of dengue virus-induced inflammasome activation in human macrophage subsets. J. Biomed. Sci. 2013, 20, 36. [CrossRef] [PubMed]
115. Cheng, Y.-L.; Lin, Y.-S.; Chen, C.-L.; Tsai, T.-T.; Tsai, C.-C.; Wu, Y.-W.; Ou, Y.-D.; Chu, Y.-Y.; Wang, J.-M.; Yu, C.-Y.; et al. Activation of Nrf2 by the dengue virus causes an increase in CLEC5A, which enhances TNF-α production by mononuclear phagocytes. Sci. Rep. 2016, 6, 32000. [CrossRef] [PubMed]
116. Inui, M.; Kikuchi, Y.; Aoki, N.; Endo, S.; Maeda, T.; Sugahara-Tobinai, A.; Fujimura, S.; Nakamura, A.; Kumanogoh, A.; Colonna, M.; Takai, T. Signal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12. Proc. Natl. Acad. Sci. USA 2009, 106, 4816-4821. [CrossRef] [PubMed]
117. Huang, Y.-L.; Chen, S.-T.; Liu, R.-S.; Chen, Y.-H.; Lin, C.-Y.; Huang, C.-H.; Shu, P.-Y.; Liao, C.-L.; Hsieh, S.-L. CLEC5A is critical for dengue virus-induced osteoclast activation and bone homeostasis. J. Mol. Med. 2016, 94, 1025-1037. [CrossRef] [PubMed]
118. Martinez-Pomares, L. The mannose receptor. J. Leukoc. Biol. 2012, 92, 1177-1186. [CrossRef] [PubMed]
119. Lai, J.; Bernhard, O.K.; Turville, S.G.; Harman, A.N.; Wilkinson, J.; Cunningham, A.L. Oligomerization of the Macrophage Mannose Receptor Enhances gp120-mediated Binding of HIV-1. J. Biol. Chem. 2009, 284, 11027-11038. [CrossRef] [PubMed]
120. Gazi, U.; Martinez-Pomares, L. Influence of the mannose receptor in host immune responses. Immunobiology 2009, 214, 554-561. [CrossRef] [PubMed]
121. Nguyen, D.G.; Hildreth, J.E.K. Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages. Eur. J. Immunol. 2003, 33, 483-493. [CrossRef] [PubMed]
122. Miller, J.L.; deWet, B.J.M.; Martinez-Pomares, L.; Radcliffe, C.M.; Dwek, R.A.; Rudd, P.M.; Gordon, S. TheMannose ReceptorMediates Dengue Virus Infection ofMacrophages. PLoS Pathog. 2008, 4, e17. [CrossRef]
123. Upham, J.P.; Pickett, D.; Irimura, T.; Anders, E.M.; Reading, P.C. Macrophage Receptors for Influenza A Virus: Role of the Macrophage Galactose-Type Lectin and Mannose Receptor in Viral Entry. J. Virol. 2010, 84, 3730-3737. [CrossRef] [PubMed]
124. Reading, P.C.; Miller, J.L.; Anders, E.M. Involvement of the Mannose Receptor in Infection of Macrophages by Influenza Virus. J. Virol. 2000, 74, 5190-5197. [CrossRef] [PubMed]
125. Op den Brouw, M.L.; Binda, R.S.; Geijtenbeek, T.B.H.; Janssen, H.L.A.; Woltman, A.M. The mannose receptor acts as hepatitis B virus surface antigen receptor mediating interaction with intrahepatic dendritic cells. Virology 2009, 393, 84-90. [CrossRef] [PubMed]
126. Zizzari, I.G.; Napoletano, C.; Battisti, F.; Rahimi, H.; Caponnetto, S.; Pierelli, L.; Nuti, M.; Rughetti, A. MGL Receptor and Immunity: When the Ligand Can Make the Difference. J. Immunol. Res. 2015, 2015, 450695. [CrossRef] [PubMed]
127. Usami, K.; Matsuno, K.; Igarashi, M.; Denda-Nagai, K.; Takada, A.; Irimura, T. Involvement of viral envelope GP2 in Ebola virus entry into cells expressing the macrophage galactose-type C-type lectin. Biochem. Biophys. Res. Commun. 2011, 407, 74-78. [CrossRef] [PubMed]
128. Takada, A.; Fujioka, K.; Tsuiji, M.; Morikawa, A.; Higashi, N.; Ebihara, H.; Kobasa, D.; Feldmann, H.; Irimura, T.; Kawaoka, Y. Human Macrophage C-Type Lectin Specific for Galactose and N-Acetylgalactosamine Promotes Filovirus Entry. J. Virol. 2004, 78, 2943-2947. [CrossRef] [PubMed]
129. Matsuno, K.; Kishida, N.; Usami, K.; Igarashi, M.; Yoshida, R.; Nakayama, E.; Shimojima, M.; Feldmann, H.; Irimura, T.; Kawaoka, Y.; et al. Different Potential of C-Type Lectin-Mediated Entry between Marburg Virus Strains. J. Virol. 2010, 84, 5140-5147. [CrossRef] [PubMed]
130. Ng, W.C.; Liong, S.; Tate, M.D.; Irimura, T.; Denda-Nagai, K.; Brooks, A.G.; Londrigan, S.L.; Reading, P.C. The Macrophage Galactose-Type Lectin Can Function as an Attachment and Entry Receptor for Influenza Virus. J. Virol. 2014, 88, 1659-1672. [CrossRef] [PubMed]
131. Bernardi, A.; Jiménez-Barbero, J.; Casnati, A.; De Castro, C.; Darbre, T.; Fieschi, F.; Finne, J.; Funken, H.; Jaeger, K.-E.; Lahmann, M.; et al. Multivalent glycoconjugates as anti-pathogenic agents. Chem. Soc. Rev. 2013, 42, 4709-4727. [CrossRef] [PubMed]
132. Lepenies, B.; Lee, J.; Sonkaria, S. Targeting C-type lectin receptors with multivalent carbohydrate ligands. Adv. Drug Deliv. Rev. 2013, 65, 1271-1281. [CrossRef] [PubMed]
133. Johannssen, T.; Lepenies, B. Glycan-Based Cell Targeting To Modulate Immune Responses. Trends Biotechnol. 2016. [CrossRef] [PubMed]
134. Kiessling, L.L.; Splain, R.A. Chemical Approaches to Glycobiology. Annu. Rev. Biochem. 2010, 79, 619-653. [CrossRef] [PubMed]
135. Joshi, M.D.; Unger, W.J.; Storm, G.; van Kooyk, Y.; Mastrobattista, E. Targeting tumor antigens to dendritic cells using particulate carriers. J. Control. Release 2012, 161, 25-37. [CrossRef] [PubMed]
136. Becer, C.R. The glycopolymer code: Synthesis of glycopolymers and multivalent carbohydrate-lectin interactions. Macromol. Rapid Commun. 2012, 33, 742-752. [CrossRef] [PubMed]
137. Berzi, A.; Reina, J.J.; Ottria, R.; Sutkeviciute, I.; Antonazzo, P.; Sanchez-Navarro, M.; Chabrol, E.; Biasin, M.; Trabattoni, D.; Cetin, I.; et al. A glycomimetic compound inhibits DC-SIGN-mediated HIV infection in cellular and cervical explant models. AIDS 2012, 26. [CrossRef] [PubMed]
138. Mintzer, M.A.; Dane, E.L.; O’Toole, G.A.; Grinstaff, M.W. Exploiting Dendrimer Multivalency to Combat Emerging and Re-Emerging Infectious Diseases. Mol. Pharm. 2012, 9, 342-354. [CrossRef] [PubMed]
139. Vincent, S.P.; Buffet, K.; Nierengarten, I.; Imberty, A.; Nierengarten, J.-F. Biologically Active Heteroglycoclusters Constructed on a Pillar[5]arene-Containing [2]Rotaxane Scaffold. Chem. Eur. J. 2016, 22, 88-92. [CrossRef] [PubMed]
140. Jayaraman, N. Multivalent ligand presentation as a central concept to study intricate carbohydrate-protein interactions. Chem. Soc. Rev. 2009, 38, 3463-3483. [CrossRef] [PubMed]
141. Maglinao, M.; Eriksson, M.; Schlegel, M.K.; Zimmermann, S.; Johannssen, T.; Götze, S.; Seeberger, P.H.; Lepenies, B. A platform to screen for C-type lectin receptor-binding carbohydrates and their potential for cell-specific targeting and immune modulation. J. Control. Release 2014, 175, 36-42. [CrossRef] [PubMed]
142. Brzezicka, K.; Vogel, U.; Serna, S.; Johannssen, T.; Lepenies, B.; Reichardt, N.-C. Influence of Core β-1,2-Xylosylation on Glycoprotein Recognition by Murine C-type Lectin Receptors and Its Impact on Dendritic Cell Targeting. ACS Chem. Biol. 2016. [CrossRef] [PubMed]
143. Eriksson, M.; Serna, S.; Maglinao, M.; Schlegel, M.K.; Seeberger, P.H.; Reichardt, N.-C.; Lepenies, B. Biological Evaluation of Multivalent Lewis X-MGL-1 Interactions. ChemBioChem 2014, 15, 844-851. [CrossRef] [PubMed]
144. García-Vallejo, J.J.; Unger, W.W.J.; Kalay, H.; van Kooyk, Y. Glycan-based DC-SIGN targeting to enhance antigen cross-presentation in anticancer vaccines. Oncoimmunology 2013, 2, e23040. [CrossRef] [PubMed]
145. van Kooyk, Y.; Unger, W.W.J.; Fehres, C.M.; Kalay, H.; García-Vallejo, J.J. Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation. Mol. Immunol. 2013, 55, 143-145. [CrossRef] [PubMed]
146. Martínez-Ávila, O.; Hijazi, K.; Marradi, M.; Clavel, C.; Campion, C.; Kelly, C.; Penadés, S. Gold Manno-Glyconanoparticles: Multivalent Systems to Block HIV-1 gp120 Binding to the Lectin DC-SIGN. Chem. Eur. J. 2009, 15, 9874-9888. [CrossRef] [PubMed]
147. Arnáiz, B.; Martínez-Ávila, O.; Falcon-Perez, J.M.; Penadés, S. Cellular Uptake of Gold Nanoparticles Bearing HIV gp120 Oligomannosides. Bioconjug. Chem. 2012, 23, 814-825. [CrossRef] [PubMed]
148. Martínez-Ávila, O.; Bedoya, L.M.; Marradi, M.; Clavel, C.; Alcamí, J.; Penadés, S. Multivalent Manno-Glyconanoparticles Inhibit DC-SIGN-Mediated HIV-1 Trans-Infection of Human T cells. ChemBioChem 2009, 10, 1806-1809. [CrossRef] [PubMed]
149. Garcia-Vallejo, J.J.; Koning, N.; Ambrosini, M.; Kalay, H.; Vuist, I.; Sarrami-Forooshani, R.; Geijtenbeek, T.B.H.; van Kooyk, Y. Glycodendrimers prevent HIV transmission via DC-SIGN on dendritic cells. Int. Immunol. 2013, 25, 221-233. [CrossRef] [PubMed]
150. Shiao, T.C.; Roy, R. Glycodendrimers as functional antigens and antitumor vaccines. New J. Chem. 2012, 36, 324-339. [CrossRef]
151. Varga, N.; Sutkeviciute, I.; Ribeiro-Viana, R.; Berzi, A.; Ramdasi, R.; Daghetti, A.; Vettoretti, G.; Amara, A.; Clerici, M.; Rojo, J.; Fieschi, F.; Bernardi, A. A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus. Biomaterials 2014, 35, 4175-4184. [CrossRef] [PubMed]
152. Ordanini, S.; Varga, N.; Porkolab, V.; Thepaut, M.; Belvisi, L.; Bertaglia, A.; Palmioli, A.; Berzi, A.; Trabattoni, D.; Clerici, M.; Fieschi, F.; Bernardi, A. Designing nanomolar antagonists of DC-SIGN-mediated HIV infection: Ligand presentation using molecular rods. Chem. Commun. 2015, 51, 3816-3819. [CrossRef] [PubMed]
153. Sattin, S.; Daghetti, A.; Thépaut, M.; Berzi, A.; Sánchez-Navarro, M.; Tabarani, G.; Rojo, J.; Fieschi, F.; Clerici, M.; Bernardi, A. Inhibition of DC-SIGN-Mediated HIV Infection by a Linear Trimannoside Mimic in a Tetravalent Presentation. ACS Chem. Biol. 2010, 5, 301-312. [CrossRef] [PubMed]
154. Luczkowiak, J.; Sattin, S.; Sutkevičiutė, I.; Reina, J.J.; Sánchez-Navarro, M.; Thépaut, M.; Martínez-Prats, L.; Daghetti, A.; Fieschi, F.; Delgado, R.; et al. Pseudosaccharide Functionalized Dendrimers as Potent Inhibitors of DC-SIGN Dependent Ebola Pseudotyped Viral Infection. Bioconjug. Chem. 2011, 22, 1354-1365. [CrossRef] [PubMed]
155. Nierengarten, J.-F.; Iehl, J.; Oerthel, V.; Holler, M.; Illescas, B.M.; Munoz, A.; Martin, N.; Rojo, J.; Sanchez-Navarro, M.; Cecioni, S.; et al. Fullerene sugar balls. Chem. Commun. 2010, 46, 3860-3862. [CrossRef] [PubMed]
156. Luczkowiak, J.; Muñoz, A.; Sánchez-Navarro, M.; Ribeiro-Viana, R.; Ginieis, A.; Illescas, B.M.; Martín, N.; Delgado, R.; Rojo, J. Glycofullerenes Inhibit Viral Infection. Biomacromolecules 2013, 14, 431-437. [CrossRef] [PubMed]
157. Muñoz, A.; Sigwalt, D.; Illescas, B.M.; Luczkowiak, J.; Rodríguez-Pérez, L.; Nierengarten, I.; Holler, M.; Remy, J.-S.; Buffet, K.; Vincent, S.P.; et al. Synthesis of giant globular multivalent glycofullerenes as potent inhibitors in a model of Ebola virus infection. Nat. Chem. 2016, 8, 50-57. [CrossRef] [PubMed]
158. Vidal, S. Glycofullerenes: Sweet fullerenes vanquish viruses. Nat. Chem. 2016, 8, 4-6. [CrossRef] [PubMed]
159. Ribeiro-Viana, R.; Sánchez-Navarro, M.; Luczkowiak, J.; Koeppe, J.R.; Delgado, R.; Rojo, J.; Davis, B.G. Virus-like glycodendrinanoparticles displaying quasi-equivalent nested polyvalency upon glycoprotein platforms potently block viral infection. Nat. Commun. 2012, 3, 1303. [CrossRef] [PubMed]
160. Smith, D.F.; Cummings, R.D. Investigating Virus-Glycan Interactions Using Glycan Microarrays. Curr. Opin. Virol. 2014, 7, 79-87. [CrossRef] [PubMed]
161. Khatri, K.; Klein, J.A.; White, M.R.; Grant, O.C.; Leymarie, N.; Woods, R.J.; Hartshorn, K.L.; Zaia, J. Integrated Omics and Computational Glycobiology Reveal Structural Basis for Influenza A Virus Glycan Microheterogeneity and Host Interactions. Mol. Cell. Proteom. 2016, 15, 1895-1912. [CrossRef] [PubMed]